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A successful approach has been developed for the sequencing of apolipoprotein B based upon the 
procedure of Cleveland et al. [(1977) J. Biol. Chem. 252, 1102-l 1061 involving limited proteolysis in the 
presence of sodium dodecyl sulfate. Staphylococcus aureus protease was employed to produce large 
peptides which were isolated in relatively pure form by preparative gel electrophoresis. Two peptides were 
partially sequenced using spinning-cup microsequencing techniques. The sequences are: Peptide R2-5, 
-Ala - Leu - Val - Gly - Ile - Asn - Gly - Glu -Ala - Asn - Leu - Asp - Phe - Leu - Asn - Ile - Pro - Leu - Arg - Ile - Pro- 
Pro-Met-Arg-(Arg)-; and Peptide R3-1, -Leu-Val-Ala-Lys-Pro-Ser-Val-Ser-Val-Glu-Phe-Val-Thr 
-Asn-Met-Gly-Ile-Ile-Ile-Pro-Lys-Phe-Ala-Arg-. Several stretches of residues suitable for the construction 
of oligonucleotide probes have been identified. 
Apofipoprotein B Amino acid sequence Proteolysis 
Polypeptide composition 
LDL Protein isolation 
1. INTRODUCTION 
Apolipoprotein B is the major protein of human 
low density lipoproteins and it is composed of a 
single polypeptide chain with a molecular mass 
estimated to be 250-500 kDa [1,2]. Apolipopro- 
tein B (apo-B) binds to lipid avidly, although its 
amino acid composition [3] is not particularly 
enriched in hydrophobic residues. Thus, apo-B 
may bind to lipid through stretches of hydrophobic 
amino acids, or even by covalent attachment o 
lipid. 
It is of particular interest to examine the amino 
acid sequence of apo-B to investigate its lipid bind- 
ing properties. Further, several forms of apo-B 
have been identified [3-71 and the structural rela- 
tionships between these forms are not known. Se- 
quence information would allow the construction 
of oligonucleotide probes which may ultimately be 
useful in examining its genetic structure in detail, 
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as well as the processing of the apo-B message and 
the regulation of translation and transcription. 
The hydrophobicity [8], large size and an ap- 
parently blocked N-terminus contribute to the dif- 
ficulties in sequencing apo-B. Here we report that 
a successful approach has been developed for 
generating sequence information for apo-B based 
on the procedure in [9] involving limited pro- 
teolysis in the presence of sodium dodecyl sulfate 
(SDS). Staphylococcus aureus protease was 
employed to produce large peptides which were 
isolated by preparative gel electrophoresis in quan- 
tities sufficient for amino acid sequencing. These 
sequences are presented here, and several peptides 
suitable for the construction of oligonucleotide 
probes are indicated. 
2. EXPERIMENTAL 
2.1. Isolation of low density lipoproteins 
Plasma was obtained from a normolipemic 
donor and LDL isolated by differential ultracen- 
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trifugation, using gentamycin, azide and EDTA 
[l]. The LDL used here were isolated between the 
densities of 1.02 and 1.05 g/ml. 
2.2. Proteolytic digestion of apolipoprotein B 
2.2.1. Analytical digestion 
To find optimal conditions for limited pro- 
teolysis of apo-B, we varied protease concentration 
and the incubation time and examined the resulting 
peptide fragments by polyacrylamide gel elec- 
trophoresis in the presence of SDS. The proteolytic 
reaction was carried out by mixing 80 pg apo-B, as 
intact LDL, with a more concentrated reaction 
buffer to give a final volume of 100~1 in 125 mM 
Tris-HCl (pH 6.8) containing 0.5% SDS, 10% 
glycerol and 0.001% bromophenol blue. This mix- 
ture was heated to 100°C for 2 min and cooled on 
ice. Between 2 and 20 pg of S. aureus protease was 
added, and samples were incubated at 37°C for 
times ranging from 30 min to 3 h. The individual 
reactions were stopped by the addition of SDS and 
2-mercaptoethanol to final concentrations of 2 and 
lo%, respectively. The mixtures were boiled for 
2 min and cooled to room temperature before be- 
ing applied to a 15% polyacrylamide SDS slab gel 
for electrophoretic separation of digestion 
peptides. 
2.2.2. Preparative digestion 
Six mg of apo-B, as intact LDL, was mixed with 
the reaction buffer given above in a final volume 
of 2.8 ml. This mixture was incubated at 100°C for 
3 min and cooled on ice, then 87 ,ug of S. aureus 
protease was added, and the mixture incubated at 
37°C for 75 min. The proteolysis was stopped with 
SDS and 2-mercaptoethanol as described above. 
The mixture was boiled for 3 min and applied to 2 
slab polyacrylamide gels of 14 cm x 18 cm x 
3 mm. 
2.3. Treatment of slab gels 
Electrophoresis of the preparative digestion 
samples proceeded until the tracking dye was 
within 1 cm of the gel bottom. The gels were 
stained for 45 min with 0.25% Coomassie brilliant 
blue in 50% methanol and 10% acetic acid and de- 
stained for about 45 min in 50% methanol and 7% 
acetic acid. The gels were soaked at 4°C overnight 
in distilled water. 
Polyacrylamide gel strips containing peptide 
106 
bands were sliced out of the preparative gels with 
a scalpel. In some cases, band slices were stored 
frozen in polypropylene tubes at -20°C until 
elution. 
2.4. Gel electroelution 
Protein was eluted from the acrylamide gel 
bands electrophoretically using an electroelution 
apparatus (CBS Scientific Co., Del Mar, CA) con- 
sisting of a bridge extending between 2 buffer 
chambers. The running buffer was 0.05 M Tris- 
acetate (pH 7.8) with 0.05% SDS. The bridge was 
bounded on both ends by dialysis membranes 
(Spectra/Par), and on one side was placed the strip 
of acrylamide gel containing the peptide band. 
Following elution for 24 h at 60 mA, protein plus 
Coomassie stain was collected from the anodal side 
of the bridge structure in a small volume (100 pl), 
retained by the dialysis membrane. The protein 
samples were dialyzed againsts 5 mM ammonium 
bicarbonate before further analysis. 
2.5. Amino acid sequencing 
The amino acid composition of digestion pep- 
tides and the amino acid sequencing were carried 
out as in [lo-121. 
3. RESULTS AND DISCUSSION 
S. aureus protease cleaves peptide bonds on the 
C-terminal side of glutamic acid residues. Based on 
the amino acid composition of apo-B with about 
400 glutamate residues, a large number of peptide 
fragments are expected upon complete proteolysis. 
By limiting the extent of proteolysis by including 
SDS in the reaction mixture and by limiting in- 
cubation time and enzyme concentration, fewer 
peptides are formed, and most of these are large 
enough to be retained by polyacrylamide gels. Fur- 
ther, since all peptide bonds are not equally sen- 
sitive to proteolysis, some peptides exist in 
disproportionately high concentrations. 
Under our digestion conditions, apolipoprotein 
B was fragmented into at least 20 peptides of 
molecular masses between 15 and 70 kDa (fig.1). 
Digestion under varying conditions of time and 
protease concentrations yielded remarkably similar 
peptide patterns, with the steady loss of higher 
molecular mass peptides with increasing protease 
and incubation times. These patterns were 
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Fig. 1. Preparative polyacrylamide gel electrophoresis of 
human apo-B peptides. S. aureus protease peptides were 
generated from apo-B and run on a 15% polyacrylamide 
gel as described in the text. The peptides R2-5 and R3-1 
are indicated by arrows, and i14, markers are indicated 
on the left (ovalbumin, 45000; carbonic anhydrose, 
32000; fl-lactalbumin, 18000). k, kDa. 
reproducible, at least using LDL isolated from the 
same individual. APO-B incubated in the absence 
of the protease remained intact throughout the 
longest incubation period. At 60 min incubation 
time and 40pg/ml protease, there appeared to be 
a slight increase in a peptide labeled R3-1 which 
appeared to be resolved from other peptides. We 
chose similar conditions for our large-scale diges- 
tion of human apo-B. 
The purity and size of 7 isolated peptides are 
shown in table 1. The peptides ranged in size from 
about 22 to 68 kDa. While several peptide frac- 
tions (3,4) contained more than one band when 
rerun, most fractions appeared as a single peptide 
band on SDS-polyacrylamide gels. We did not ex- 
plore whether or not several proteins of similar 
molecular mass but differing charge contributed to 
each band on our SDS gels, but as shown below, 
Table 1 
Quantitative analysis of isolated peptides 
Band Apparent Quantity Yield 
Mr kg) nmol (%) 
1 68000 32 0.5 16 
2 52000 8 0.2 9 
3 50000 6 0.1 10 
4 47000 30 0.6 18 
5 43000 15 0.4 12 
R2-5 24000 54 2.2 14 
R3-1 22000 49 2.2 10 
the two peptides selected for sequencing gave 
unique sequences. 
The mass of protein was initially estimated by 
comparing the amount of Coomassie stain within 
each band to that of bovine serum albumin stan- 
dards run on the same acrylamide gel. On this 
basis, the yield of peptide protein was low, ranging 
from about 10 to 20% recovery. Subsequent to the 
work presented here, we have increased our yield 
2-fold by increasing the time of elution from 24 h 
to 48 h. Two peptides, R2-5 and R3-1, each yielded 
about 2 nmol of protein (table 1) and were submit- 
ted for amino acid sequence determinations. 
In fig.2 are given partial sequences of two pep- 
tides of apparent molecular masses of 22 and 
24 kDa. Using microsequencing techniques, the se- 
quence of the first 24 residues of each peptide were 
obtained, starting at the N-terminal end, from only 
2 nmol of peptide protein. The sequences of our 
human apo-B peptides are not homologous to any 
of the sequences reported for other apolipopro- 
teins, including apo-A-I, A-II, E and C-peptides 
[13,14]. The apo-B peptides are also not 
homologous to the sequence of S. aureus protease 
[151. 
The thrust of much of the recent biochemical 
work concerning apolipoproteins has involved 
molecular cloning techniques. In the case of apo- 
B, this approach should prove particularly fruitful 
in terms of determining the sequence and absolute 
size of this protein through analysis of the DNA. 
We have identified several regions within the 
amino acid sequences presented for peptides R2-5 
and R3-1, which are suitable for the construction 
of oligonucleotide probes. Two of these are in- 
dicated in fig.2. We have synthesized these and 
other probes and are currently characterizing 
several potential apo-B clones identified from our 
human liver cDNA and genomic libraries. 
R2-5: -ALh-LELl-VAL-GLY-ILE-ASN-GLY-GLU-ALA-ASN- 
LEU-ASP-PHE-LEU-ASN-ILE-PRO-LEU-ARG-ILE- 
PRO-PRO-MET-ARG- (ARG) - 
R3-1: -LEU-VAL-ALA-LYS-PRO-SER-VAL-SER-VAL-GLU- 
PHE-VAL-THR-ASN-MET-GLY-ILE-ILE-ILE-PRO- 
LYS-PHE-ALA-ARG- 
Fig.2. Sequences of human apo-B peptides, R2-5 and 
R3-1. Underlined regions were used to construct 
oligonucleotide probes. 
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